Aquestive Therapeutics, Inc. (AQST): Price and Financial Metrics
AQST Price/Volume Stats
| Current price | $3.57 | 52-week high | $5.80 |
| Prev. close | $3.41 | 52-week low | $2.12 |
| Day low | $3.38 | Volume | 2,090,400 |
| Day high | $3.59 | Avg. volume | 1,602,637 |
| 50-day MA | $2.72 | Dividend yield | N/A |
| 200-day MA | $3.70 | Market Cap | 354.60M |
AQST Stock Price Chart Interactive Chart >
Aquestive Therapeutics, Inc. (AQST) Company Bio
Aquestive Therapeutics, Inc. operates as a specialty pharmaceutical company that specializes in the drug delivery technology. The company offers PharmFilm, a drug delivery platform/pharmaceutical dosage form that delivers existing prescription products directly to the bloodstream. It develops, manufactures, and commercializes pharmaceutical films, individual film doses, and finished products for patients, physicians, and caregivers. Aquestive Therapeutics, Inc. was formerly known as MonoSol Rx Inc. and changed its name to Aquestive Therapeutics, Inc. in November 2017. The company was founded in 2000 and is based in Warren, New Jersey.
AQST Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AQST Price Returns
| 1-mo | 30.77% |
| 3-mo | 34.72% |
| 6-mo | -14.39% |
| 1-year | 27.05% |
| 3-year | 305.59% |
| 5-year | -30.68% |
| YTD | 0.28% |
| 2024 | 76.24% |
| 2023 | 123.92% |
| 2022 | -76.81% |
| 2021 | -27.29% |
| 2020 | -8.08% |